CT
ABBV icon

Chicago Trust’s AbbVie ABBV Stock Holding History

Chicago Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
55,260
+483
+0.9% +$104K 2.01% 8
2026
Q1 		$11.9M Sell
54,777
-2,153
-4% -$478K 1.9% 9
2025
Q4 		$13M Sell
56,930
-2,702
-5% -$616K 2.03% 7
2025
Q3 		$13.8M Sell
59,632
-7,129
-11% -$1.45M 1.92% 8
2025
Q2 		$12.4M Buy
66,761
+4,276
+7% +$795K 1.74% 11
2025
Q1 		$13.1M Sell
62,485
-1,115
-2% -$217K 2.32% 7
2024
Q4 		$11.3M Sell
63,600
-132
-0.2% -$24.3K 2% 8
2024
Q3 		$12.6M Buy
63,732
+2,199
+4% +$410K 2.17% 6
2024
Q2 		$10.6M Sell
61,533
-3,661
-6% -$606K 2.14% 8
2024
Q1 		$11.9M Buy
65,194
+815
+1% +$140K 2.46% 6
2023
Q4 		$9.98M Sell
64,379
-7,028
-10% -$1.02M 2.22% 7
2023
Q3 		$10.6M Sell
71,407
-4,115
-5% -$604K 2.67% 5
2023
Q2 		$10.2M Sell
75,522
-1,771
-2% -$260K 2.44% 5
2023
Q1 		$12.3M Buy
77,293
+9,163
+13% +$1.4M 3.09% 4
2022
Q4 		$11M Sell
68,130
-4,859
-7% -$745K 2.75% 5
2022
Q3 		$9.79M Sell
72,989
-885
-1% -$127K 2.54% 5
2022
Q2 		$11.3M Buy
73,874
+2,268
+3% +$347K 2.85% 4
2022
Q1 		$11.6M Sell
71,606
-2,512
-3% -$365K 2.49% 4
2021
Q4 		$10M Buy
74,118
+579
+0.8% +$68.4K 2% 4
2021
Q3 		$7.93M Buy
73,539
+5,527
+8% +$632K 1.74% 5
2021
Q2 		$7.66M Buy
68,012
+8,381
+14% +$944K 1.81% 4
2021
Q1 		$6.45M Sell
59,631
-4,529
-7% -$484K 2.22% 4
2020
Q4 		$6.88M Buy
64,160
+3,952
+7% +$380K 2.36% 3
2020
Q3 		$5.27M Sell
60,208
-4,399
-7% -$414K 2.2% 4
2020
Q2 		$6.34M Buy
64,607
+616
+1% +$54.2K 2.81% 4
2020
Q1 		$4.88M Sell
63,991
-1,505
-2% -$128K 2.47% 5
2019
Q4 		$5.8M Sell
65,496
-207
-0.3% -$17.2K 2.36% 4
2019
Q3 		$4.97M Buy
65,703
+2,521
+4% +$173K 2.1% 7
2019
Q2 		$4.59K Buy
63,182
+3,669
+6% +$288K 1.96% 7
2019
Q1 		$4.8K Sell
59,513
-749
-1% -$61.3K 2.07% 6
2018
Q4 		$5.56K Sell
60,262
-302
-0.5% -$26.6K 2.63% 5
2018
Q3 		$5.73M Sell
60,564
-24,437
-29% -$2.32M 2.28% 7
2018
Q2 		$7.88M Sell
85,001
-1,393
-2% -$136K 3.35% 3
2018
Q1 		$8.18M Buy
86,394
+790
+0.9% +$86.8K 3.49% 3
2017
Q4 		$8.28M Sell
85,604
-437
-0.5% -$41.2K 3.31% 3
2017
Q3 		$7.65K Buy
86,041
+1,132
+1% +$86.2K 3.22% 3
2017
Q2 		$6.16K Sell
84,909
-6,975
-8% -$469K 2.73% 3
2017
Q1 		$5.99K Sell
91,884
-6,143
-6% -$386K 2.65% 4
2016
Q4 		$6.14M Sell
98,027
-15,113
-13% -$922K 2.66% 3
2016
Q3 		$7.14M Sell
113,140
-23,367
-17% -$1.51M 3.11% 1
2016
Q2 		$8.45M Sell
136,507
-1,940
-1% -$118K 3.47% 1
2016
Q1 		$7.91M Sell
138,447
-4,515
-3% -$252K 3.28% 1
2015
Q4 		$8.47M Sell
142,962
-3,428
-2% -$197K 3.29% 2
2015
Q3 		$7.97M Sell
146,390
-1,236
-0.8% -$80.5K 3.06% 3
2015
Q2 		$9.92M Buy
147,626
+273
+0.2% +$17.8K 3.49% 2
2015
Q1 		$8.63M Buy
+147,353
New +$8.9M 2.96% 2

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Chicago Trust's ABBV Position: Q2 2026 in Review

Chicago Trust increased its AbbVie (ABBV) stake by 0.88% in Q2 2026, buying an estimated $104K and bringing the position to 55,260 shares worth $13.9M. The position accounts for 2.01% of the portfolio, ranked #8.

Chicago Trust first reported a position in ABBV in Q1 2015 and has held it in 46 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chicago Trust held 55,260 shares of AbbVie worth $13.9M as of Q2 2026.
  • Chicago Trust bought 483 AbbVie shares in Q2 2026, an estimated $104K.
  • AbbVie made up 2.01% of Chicago Trust's portfolio in Q2 2026, its #8 holding.
  • Chicago Trust first reported a position in AbbVie in Q1 2015 and has held it in 46 quarters since.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.